Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters-Reference-Cited by-同舟云学术

Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters

Published:2022-08 Issue:33 Volume:40 Page:4676-4681
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

de Swart Rik L.,de Leeuw Olav S.,Oreshkova Nadia,Gerhards Nora M.,Albulescu Irina C.,Vreman Sandra,Gonzales José L.,Maas Riks,van Kuppeveld Frank J.M.,Soema Peter,Bosch Berend-Jan,Peeters Ben P.H.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. ICTV virus taxonomy profile: paramyxoviridae;Rima;J Gen Virol,2019

2. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence;Peeters;J Virol,1999

3. Exploring the prospects of engineered newcastle disease virus in modern vaccinology;Bello;Viruses,2020

4. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens;DiNapoli;Proc Natl Acad Sci U S A,2007

5. Process development for newcastle disease virus-vectored vaccines in serum-free vero cell suspension cultures;Fulber;Vaccines (Basel),2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques;Vaccines;2024-04-10

2. Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization;Antiviral Research;2023-12

3. Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines;Current Opinion in Virology;2023-10

4. Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus;Journal of General Virology;2023-05-15